No Record Found
Sector
PharmaceuticalsOpen
₹290.85Prev. Close
₹290.85Turnover(Lac.)
₹1.36Day's High
₹294.7Day's Low
₹28552 Week's High
₹51152 Week's Low
₹271.1Book Value
₹232.38Face Value
₹10Mkt Cap (₹ Cr.)
89.34P/E
18.55EPS
15.59Divi. Yield
0.35No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 3.09 | 3.09 | 3.09 | 3.09 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 68.71 | 61.91 | 60.05 | 43.73 |
Net Worth | 71.8 | 65 | 63.14 | 46.82 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 179.01 | 137.45 | 111.13 | 92.52 |
yoy growth (%) | 30.23 | 23.67 | 20.12 | 30.19 |
Raw materials | -164.24 | -125.61 | -102.62 | -81.92 |
As % of sales | 91.74 | 91.38 | 92.33 | 88.54 |
Employee costs | -1.49 | -1.44 | -1.38 | -1.29 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 7.36 | 5.79 | 2.15 | 4.92 |
Depreciation | -0.49 | -0.42 | -0.41 | -0.41 |
Tax paid | -2.01 | -1.54 | -0.62 | -1.7 |
Working capital | 3.61 | 5.53 | -1.22 | 5.89 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 30.23 | 23.67 | 20.12 | 30.19 |
Op profit growth | 30.75 | 108.66 | -46.6 | 61.6 |
EBIT growth | 27.49 | 110.67 | -44.39 | 69.61 |
Net profit growth | 25.87 | 175.9 | -52.26 | 83.35 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,689.85 | 81.4 | 4,05,451.62 | 753.53 | 0.95 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,746.15 | 76.66 | 1,79,089.09 | 557 | 0.44 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,501.65 | 23.34 | 1,21,298.96 | 1,210.53 | 1.07 | 4,495.16 | 411.56 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,559.1 | 60.59 | 1,20,450.71 | 551 | 0.17 | 2,567 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,197.75 | 18.52 | 99,965.86 | 387.3 | 0.67 | 4,602.9 | 377.57 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Lalit Mehta
ED / WTD / CFO / Promoter
Rajesh Mehta
Whole Time Executive Director
Megh Mehta
Independent Non Exe. Director
Manishkumar Pipalia
Independent Non Exe. Director
Sachin Kothary
Independent Non Exe. Director
Megha Jain
Independent Non Exe. Director
Piyush Dharod
Company Sec. & Compli. Officer
Nishant Kankaria
Plot No A2/3445,
GIDC Phase IV,
Gujarat - 393002
Tel: 91-2646-220774
Website: http://www.samratpharmachem.com
Email: contact@samratpharmachem.in
C-13 Pannalal Silk,
Mills Cmpd LBS Marg, Bhandup West,
Mumbai - 400 078
Tel: 91-022-25963838
Website: www.linkintime.co.in
Email: rnt.helpdesk@linkintime.co.in/mumbai@linkintime.co.in
Summary
Samrat Pharmachem Limited was incorporated on June 16, 1992. The Companys principal activities are manufacturing and selling chemicals.The Company floated a new 100% subsidiary company during the year...
Read More
Reports by Samrat Pharmachem Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.